INZY vs. AXSM
Compare and contrast key facts about Inozyme Pharma, Inc. (INZY) and Axsome Therapeutics, Inc. (AXSM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: INZY or AXSM.
Performance
INZY vs. AXSM - Performance Comparison
Returns By Period
In the year-to-date period, INZY achieves a -36.85% return, which is significantly lower than AXSM's 23.37% return.
INZY
-36.85%
-47.36%
-41.01%
-27.30%
N/A
N/A
AXSM
23.37%
6.27%
32.37%
63.38%
23.97%
N/A
Fundamentals
| INZY | AXSM | |
|---|---|---|
| Market Cap | $179.23M | $4.76B |
| EPS | -$1.55 | -$6.58 |
| Total Revenue (TTM) | $1.98M | $338.46M |
| Gross Profit (TTM) | $1.11M | $306.46M |
| EBITDA (TTM) | -$88.15M | -$300.59M |
Key characteristics
| INZY | AXSM | |
|---|---|---|
| Sharpe Ratio | -0.48 | 1.55 |
| Sortino Ratio | -0.37 | 2.18 |
| Omega Ratio | 0.96 | 1.27 |
| Calmar Ratio | -0.33 | 1.52 |
| Martin Ratio | -0.98 | 4.22 |
| Ulcer Index | 30.40% | 15.62% |
| Daily Std Dev | 62.29% | 42.55% |
| Max Drawdown | -96.52% | -86.65% |
| Current Drawdown | -91.09% | -7.58% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between INZY and AXSM is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
INZY vs. AXSM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Inozyme Pharma, Inc. (INZY) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
INZY vs. AXSM - Dividend Comparison
Neither INZY nor AXSM has paid dividends to shareholders.
Drawdowns
INZY vs. AXSM - Drawdown Comparison
The maximum INZY drawdown since its inception was -96.52%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for INZY and AXSM. For additional features, visit the drawdowns tool.
Volatility
INZY vs. AXSM - Volatility Comparison
Inozyme Pharma, Inc. (INZY) has a higher volatility of 15.85% compared to Axsome Therapeutics, Inc. (AXSM) at 12.86%. This indicates that INZY's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
INZY vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Inozyme Pharma, Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities